Blood test for depression?

Blood test for depression?
Found to accurately distinguish depressed patients from healthy controls

“Traditionally, diagnosis of major depression and other mental disorders has been made based on patients’ reported symptoms, but the accuracy of that process varies a great deal, often depending on the experience and resources of the clinician conducting the assessment,” says George Papakostas, an associate professor of psychiatry at Harvard Medical School and lead and corresponding author of the report./ Amanda Swinhart/Harvard Staff Photographer

The initial assessment of a blood test to help diagnose major depressive disorder indicates it may become a useful clinical tool.

In a paper published in the journal Molecular Psychiatry, a team including Harvard-affiliated Massachusetts General Hospital (MGH) researchers reports that a test analyzing levels of nine biomarkers accurately distinguished patients diagnosed with depression from control participants without significant false-positive results.

“Traditionally, diagnosis of major depression and other mental disorders has been made based on patients’ reported symptoms, but the accuracy of that process varies a great deal, often depending on the experience and resources of the clinician conducting the assessment,” says George Papakostas of the MGH Department of Psychiatry and an associate professor of psychiatry at Harvard Medical School, lead and corresponding author of the report.  “Adding an objective biological test could improve diagnostic accuracy and may also help us track individual patients’ response to treatment.”

The study authors note that previous efforts to develop tests based on a single blood or urinary biomarker did not produce results of sufficient sensitivity, the ability to detect the tested-for condition, or specificity, the ability to rule out that condition.  “The biology of depression suggests that a highly complex series of interactions exists between the brain and biomarkers in the peripheral circulation,” says study co-author John Bilello, chief scientific officer of Ridge Diagnostics, which sponsored the current study. ”Given the complexity and variability of these types of disorders and the associated biomarkers in an individual, it is easy to understand why approaches measuring a single factor would not have sufficient clinical utility.”

The test developed by Ridge Diagnostics measures levels of nine biomarkers associated with factors such as inflammation, the development and maintenance of neurons, and the interaction between brain structures involved with stress response and other key functions. Those measurements are combined using a specific formula to produce a figure called the MDDScore — a number from 1 to 100 indicating the percentage likelihood that the individual has major depression.  In clinical use the MDDScore would range from 1 to 10.

The initial pilot phase of the study enrolled 36 adults who had been diagnosed with major depression at the MGH, Vanderbilt University, or Cambridge Health Alliance in Cambridge, Mass., along with 43 control participants from St. Elizabeth’s Hospital in Brighton, Mass.  MDDScores for 33 of the 36 patients indicated the presence of depression, while only eight of the 43 controls had a positive test result.  The average score for patients was 85, while the average for controls was 33.  A second replication phase enrolled an additional 34 patients from the MGH and Vanderbilt, 31 of whom had a positive MDDScore result.  Combining both groups indicated that the test could accurately diagnose major depression with a sensitivity of about 90 percent and a specificity of 80 percent.

“It can be difficult to convince patients of the need for treatment based on the sort of questionnaire now used to rank their reported symptoms,” says Bilello.  “We expect that the biological basis of this test may provide patients with insight into their depression as a treatable disease rather than a source of self-doubt and stigma. As we accumulate additional data on the MDDScore and perform further studies, we hope it will be useful for predicting treatment response and helping to select the best therapies.”

Papakostas adds, “Determining the true utility of this test will require following this small research study with larger trials in clinical settings.  But these results are already providing us with intriguing new hints on how powerfully factors such as inflammation — which we are learning has a major role in many serious medical issues — contribute to depression.”

By Sue McGreevey
Masschusetts General Hospital Public Affairs

###

About Harvard Medical School (HMS)

Driving Change. Building Momentum. Making History. 

“Since 1872, Harvard Medical School has been the incubator of bold ideas—a place where extraordinary people advance education, science and health care with unrelenting passion.

Whether training tomorrow’s doctors and scientists, decoding the fundamental nature of life, advancing patient care or improving health delivery systems around the world, we are never at rest. Allied with some of the world’s best hospitals, research institutes and a University synonymous with excellence, the School’s mission remains as ambitious as it is honorable: to alleviate human suffering caused by disease.”

More at Harvard Medical School & Harvard Medical School. Generations of Leaders.

_________________________________________________

###

About Harvard School of Public Health (HSPH)

Harvard School of Public Health is dedicated to advancing the public’s health through learning, discovery and communication. More than 400 faculty members are engaged in teaching and training the 1,000-plus student body in a broad spectrum of disciplines crucial to the health and well being of individuals and populations around the world. Programs and projects range from the molecular biology of AIDS vaccines to the epidemiology of cancer; from risk analysis to violence prevention; from maternal and children’s health to quality of care measurement; from health care management to international health and human rights.

More at Harvard School of Public Health (HSPH) & Harvard School of Public Health (HSPH). History.

_________________________________________________

###

About Harvard University.

Established in 1636, Harvard is the oldest institution of higher education in the United States. The University, which is based in Cambridge and Boston, Massachusetts, has an enrollment of over 20,000 degree candidates, including undergraduate, graduate, and professional students. Harvard has more than 360,000 alumni around the world.

Harvard University is devoted to excellence in teaching, learning, and research, and to developing leaders in many disciplines who make a difference globally. Harvard faculty are engaged with teaching and research to push the boundaries of human knowledge. For students who are excited to investigate the biggest issues of the 21st century, Harvard offers an unparalleled student experience and a generous financial aid program, with over $160 million awarded to more than 60% of our undergraduate students. The University has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a truly global education.

‘Universities nurture the hopes of the world: in solving challenges that cross borders; in unlocking and harnessing new knowledge; in building cultural and political understanding; and in modeling environments that promote dialogue and debate… The ideal and breadth of liberal education that embraces the humanities and arts as well as the social and natural sciences is at the core of Harvard’s philosophy. ’/ Drew Gilpin Faust

More About Harvard University & About Harvard University. Information.

###

*  The above story is adapted from materials provided by Harvard University

_________________________________________________________________